If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
The launch coincides with IBS Awareness Month in April
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
Subscribe To Our Newsletter & Stay Updated
